Oral Antidiabetic Drugs Market Report

China Oral Antidiabetic Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Oct 15, 2023
  • PAGES：197
  • REPORT CODE：GMM1858010
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Diabetes mellitus is a group of a metabolic disorder caused when the body is unable to produce required quantity of Insulin. Insulin is a hormone secreted by beta cells of the islet of Langerhans of the pancreas. Various symptoms associated with diabetes disorder include recurrent urination, increased thirst, and hunger. Diabetes can cause much chronic complication if left untreated. Some of them include acute complications like diabetic ketoacidosis, chronic kidney failure, foot ulcers, and damage to the eyes.

    Oral antidiabetic drugs have the advantages of convenience, quickness, and easy access, and are being accepted by patients. Manufacturers of oral antidiabetic drugs are also developing to produce drugs with better effects, and the global oral hypoglycemic drug market will continue to grow.

    The global growth of the oral antidiabetic drug market is mainly due to the increased prevalence of diabetic patients worldwide. This growth has continued to occur in developing countries such as India and China. Also, factors leading to an increase in the global diabetes population include sedentary lifestyles, obesity, an increase in the elderly population, and lagging healthcare services. However, the high cost of the drug is expected to limit the growth of the global oral antidiabetic market. The increase in the number of pharmaceutical companies and the emergence of advanced technologies are the key factors driving the growth of this market.

    This report elaborates on the current development of the Oral Antidiabetic Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novo Nordisk

    • Pfizer

    • Biocon

    • Sunpharma

    • Abbott

    • Novartis

    • Merck

    • Eli Lilly

    By Type:

    • Alpha-glucosidase inhibitors

    • Meglitinides

    • Sulfonylureas

    By Application:

    • Hospitals

    • Clinics

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Oral Antidiabetic Drugs Market Overview 2018-2029

    • 1.1 China Oral Antidiabetic Drugs Industry Development Overview

    • 1.2 China Oral Antidiabetic Drugs Industry Development History

    • 1.3 China Oral Antidiabetic Drugs Industry Market Size (2018-2029)

    • 1.4 China Oral Antidiabetic Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Oral Antidiabetic Drugs Production Volume, Production Value and Growth Rate of Alpha-glucosidase inhibitors (2018-2029)

      • 1.4.2 China Oral Antidiabetic Drugs Production Volume, Production Value and Growth Rate of Meglitinides (2018-2029)

      • 1.4.3 China Oral Antidiabetic Drugs Production Volume, Production Value and Growth Rate of Sulfonylureas (2018-2029)

    • 1.5 China Oral Antidiabetic Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.2 China Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

      • 1.5.3 China Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Oral Antidiabetic Drugs Market Analysis by Region

      • 1.6.1 North China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Oral Antidiabetic Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Oral Antidiabetic Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Oral Antidiabetic Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Oral Antidiabetic Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Oral Antidiabetic Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Oral Antidiabetic Drugs Industry Development

    Chapter 3 Oral Antidiabetic DrugsIndustry Chain Analysis

    • 3.1 Oral Antidiabetic Drugs Industry Chain

    • 3.2 Oral Antidiabetic Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Oral Antidiabetic Drugs Market

    • 3.3 Oral Antidiabetic Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Oral Antidiabetic Drugs Market

    Chapter 4 China Oral Antidiabetic Drugs Market, by Type

    • 4.1 China Oral Antidiabetic Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Oral Antidiabetic Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Oral Antidiabetic Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Oral Antidiabetic Drugs Production Volume and Growth Rate of Alpha-glucosidase inhibitors

      • 4.5.2 China Oral Antidiabetic Drugs Production Volume and Growth Rate of Meglitinides

      • 4.5.3 China Oral Antidiabetic Drugs Production Volume and Growth Rate of Sulfonylureas

    Chapter 5 China Oral Antidiabetic Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Oral Antidiabetic Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Oral Antidiabetic Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Oral Antidiabetic Drugs Market Size and Growth Rate of Hospitals

      • 5.5.2 China Oral Antidiabetic Drugs Market Size and Growth Rate of Clinics

      • 5.5.3 China Oral Antidiabetic Drugs Market Size and Growth Rate of Others

    Chapter 6 China Oral Antidiabetic Drugs Market, by Region

    • 6.1 China Oral Antidiabetic Drugs Production Volume and Production Value, by Region

    • 6.2 China Oral Antidiabetic Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Oral Antidiabetic Drugs Market Analysis

    • 7.1 North China Oral Antidiabetic Drugs Market, by Type

    • 7.2 North China Oral Antidiabetic Drugs Market, by Application

    Chapter 8 Central China Oral Antidiabetic Drugs Market Analysis

    • 8.1 Central China Oral Antidiabetic Drugs Market, by Type

    • 8.2 Central China Oral Antidiabetic Drugs Market, by Application

    Chapter 9 South China Oral Antidiabetic Drugs Market Analysis

    • 9.1 South China Oral Antidiabetic Drugs Market, by Type

    • 9.2 South China Oral Antidiabetic Drugs Market, by Application

    Chapter 10 East China Oral Antidiabetic Drugs Market Analysis

    • 10.1 East China Oral Antidiabetic Drugs Market, by Type

    • 10.2 East China Oral Antidiabetic Drugs Market, by Application

    Chapter 11 Northeast China Oral Antidiabetic Drugs Market Analysis

    • 11.1 Northeast China Oral Antidiabetic Drugs Market, by Type

    • 11.2 Northeast China Oral Antidiabetic Drugs Market, by Application

    Chapter 12 Southwest China Oral Antidiabetic Drugs Market Analysis

    • 12.1 Southwest China Oral Antidiabetic Drugs Market, by Type

    • 12.2 Southwest China Oral Antidiabetic Drugs Market, by Application

    Chapter 13 Northwest China Oral Antidiabetic Drugs Market Analysis

    • 13.1 Northwest China Oral Antidiabetic Drugs Market, by Type

    • 13.2 Northwest China Oral Antidiabetic Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novo Nordisk

        • 14.1.1 Novo Nordisk Company Profile

        • 14.1.2 Novo Nordisk Oral Antidiabetic Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Pfizer

        • 14.2.1 Pfizer Company Profile

        • 14.2.2 Pfizer Oral Antidiabetic Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Biocon

        • 14.3.1 Biocon Company Profile

        • 14.3.2 Biocon Oral Antidiabetic Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Sunpharma

        • 14.4.1 Sunpharma Company Profile

        • 14.4.2 Sunpharma Oral Antidiabetic Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Abbott

        • 14.5.1 Abbott Company Profile

        • 14.5.2 Abbott Oral Antidiabetic Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Novartis

        • 14.6.1 Novartis Company Profile

        • 14.6.2 Novartis Oral Antidiabetic Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Merck

        • 14.7.1 Merck Company Profile

        • 14.7.2 Merck Oral Antidiabetic Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Eli Lilly

        • 14.8.1 Eli Lilly Company Profile

        • 14.8.2 Eli Lilly Oral Antidiabetic Drugs Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Oral Antidiabetic Drugs Industry Research Conclusions

    • 15.2 Oral Antidiabetic Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Oral Antidiabetic Drugs Industry Market Size (2018-2029)

    • Figure China Oral Antidiabetic Drugs Production Volume, Production Value and Growth Rate of Alpha-glucosidase inhibitors (2018-2029)

    • Figure China Oral Antidiabetic Drugs Production Volume, Production Value and Growth Rate of Meglitinides (2018-2029)

    • Figure China Oral Antidiabetic Drugs Production Volume, Production Value and Growth Rate of Sulfonylureas (2018-2029)

    • Figure China Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure China Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Oral Antidiabetic Drugs Market Size and Growth Rate from 2018-2029

    • Figure Oral Antidiabetic Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Oral Antidiabetic Drugs Market Share by Type in 2018

    • Figure China Oral Antidiabetic Drugs Market Share by Type in 2023

    • Figure China Oral Antidiabetic Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Oral Antidiabetic Drugs Production Volume and Growth Rate of Alpha-glucosidase inhibitors (2018-2023)

    • Figure China Oral Antidiabetic Drugs Production Volume and Growth Rate of Meglitinides (2018-2023)

    • Figure China Oral Antidiabetic Drugs Production Volume and Growth Rate of Sulfonylureas (2018-2023)

    • Figure China Oral Antidiabetic Drugs Market Share by Application in 2018

    • Figure China Oral Antidiabetic Drugs Market Share by Application in 2023

    • Figure China Oral Antidiabetic Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Oral Antidiabetic Drugs Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Oral Antidiabetic Drugs Market Size and Growth Rate of Clinics (2018-2023)

    • Figure China Oral Antidiabetic Drugs Market Size and Growth Rate of Others (2018-2023)

    • Table China Oral Antidiabetic Drugs Production Volume by Region (2018-2023)

    • Table China Oral Antidiabetic Drugs Production Volume Share by Region (2018-2023)

    • Figure China Oral Antidiabetic Drugs Production Volume Share by Region (2018-2023)

    • Table China Oral Antidiabetic Drugs Production Value by Region (2018-2023)

    • Table China Oral Antidiabetic Drugs Production Value Share by Region (2018-2023)

    • Figure China Oral Antidiabetic Drugs Production Value Share by Region (2018-2023)

    • Table China Oral Antidiabetic Drugs Sales Volume by Region (2018-2023)

    • Table China Oral Antidiabetic Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Oral Antidiabetic Drugs Sales Volume Share by Region (2018-2023)

    • Table China Oral Antidiabetic Drugs Sales Value by Region (2018-2023)

    • Table China Oral Antidiabetic Drugs Sales Value Share by Region (2018-2023)

    • Figure China Oral Antidiabetic Drugs Sales Value Share by Region (2018-2023)

    • Table North China Oral Antidiabetic Drugs Production Volume by Type (2018-2023)

    • Table North China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Table North China Oral Antidiabetic Drugs Sales Volume by Application (2018-2023)

    • Table North China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Oral Antidiabetic Drugs Production Volume by Type (2018-2023)

    • Table Central China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Oral Antidiabetic Drugs Sales Volume by Application (2018-2023)

    • Table Central China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Oral Antidiabetic Drugs Production Volume by Type (2018-2023)

    • Table South China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Table South China Oral Antidiabetic Drugs Sales Volume by Application (2018-2023)

    • Table South China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Oral Antidiabetic Drugs Production Volume by Type (2018-2023)

    • Table East China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Table East China Oral Antidiabetic Drugs Sales Volume by Application (2018-2023)

    • Table East China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Oral Antidiabetic Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Oral Antidiabetic Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Oral Antidiabetic Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Oral Antidiabetic Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Oral Antidiabetic Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Oral Antidiabetic Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Oral Antidiabetic Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Oral Antidiabetic Drugs Sales Volume Share by Application (2018-2023)

    • Table Novo Nordisk Company Profile

    • Table Novo Nordisk Oral Antidiabetic Drugs Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Oral Antidiabetic Drugs Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Oral Antidiabetic Drugs Revenue, Price and Gross (2018-2023)

    • Table Sunpharma Company Profile

    • Table Sunpharma Oral Antidiabetic Drugs Revenue, Price and Gross (2018-2023)

    • Table Abbott Company Profile

    • Table Abbott Oral Antidiabetic Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Oral Antidiabetic Drugs Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Oral Antidiabetic Drugs Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Oral Antidiabetic Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US